48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis

BACKGROUND: A network meta-analysis can provide estimates of relative efficacy for treatments not directly studied in head-to-head randomized controlled trials. We estimated the relative efficacy and safety of dolutegravir (DTG) versus third agents currently recommended by guidelines, including rito...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Dipen A., Snedecor, Sonya J., Tang, Wing Yu, Sudharshan, Lavanya, Lim, Jessica W., Cuffe, Robert, Pulgar, Sonia, Gilchrist, Kim A., Camejo, Rodrigo Refoios, Stephens, Jennifer, Nichols, Garrett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154896/
https://www.ncbi.nlm.nih.gov/pubmed/25188312
http://dx.doi.org/10.1371/journal.pone.0105653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154896/
https://www.ncbi.nlm.nih.gov/pubmed/25188312
http://dx.doi.org/10.1371/journal.pone.0105653

Ejemplares similares